Home
>
National Drug Code (NDC)
>
Emtriva
Emtriva - 46014-0601-1 - (emtricitabine)
Drug Information of Emtriva
| Product NDC: | 46014-0601 |
| Proprietary Name: | Emtriva |
| Non Proprietary Name: | emtricitabine |
| Active Ingredient(s): | 200 mg/1 & nbsp; emtricitabine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Emtriva
| Product NDC: | 46014-0601 |
| Labeler Name: | Excella GmbH |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021500 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030702 |
Package Information of Emtriva
| Package NDC: | 46014-0601-1 |
| Package Description: | 30 CAPSULE in 1 BOTTLE, PLASTIC (46014-0601-1) |
NDC Information of Emtriva
| NDC Code | 46014-0601-1 |
| Proprietary Name | Emtriva |
| Package Description | 30 CAPSULE in 1 BOTTLE, PLASTIC (46014-0601-1) |
| Product NDC | 46014-0601 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | emtricitabine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20030702 |
| Marketing Category Name | NDA |
| Labeler Name | Excella GmbH |
| Substance Name | EMTRICITABINE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
